Immunotyping of blasts in refractory anaemia with excess of blasts
Authors:
- 1 June 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 84 (2) , 305-309
Abstract
Summary. A study of immunological markers was performed in 16 patients with newly diagnosed refractory anaemia with excess of blasts (RAEB) and RAEB in transformation (RAEB-T) and in 12 other patients with acute myeloid leukaemia evolving from RAEB or RAEB-T. Immunocytochemical investigation of bone marrow blasts was done using a modified indirect immunoperoxidase technique. This method permitted accurate morphological identification of blasts and other cells in bone marrow. The monoclonal antibodies used in RAEB and RAEB-T samples were anti-CD34, -c-kit, -HLA-DR and -CD13. The range of CD34 expression of blasts in RAEB samples was 1–14% (mean 6·2%) and in RAEB-T samples 29–48% (mean 35·5%). CD34 positivity was detected in 3·94% (mean 47·4%) of the bone marrow blasts in acute myeloid leukaemia evolving from RAEB and RAEB-T. Expression of c-kit was demonstrated only in a low percentage of blast cells in RAEB, RAEB-T and acute myeloid leukaemia following myelodysplasia. A high percentage (> 30%) of blasts in most patients with RAEB, RAEB-T and acute myeloid leukaemia was HLA-DR and CD13 positive. We observed the transformation from RAEB to acute myeloid leukaemia in three patients. The proportion of CD34 positive blasts increased to 25% and 32% in two patients. The third patient showed an unchanged percentage of CD34 positivity of blasts. These findings indicate that the CD34 positivity of blasts increases with the progression of myelodysplasia to RAEB-T and acute myeloid leukaemia demonstrating the instability of the clonal defect in myelodysplasia.Keywords
This publication has 20 references indexed in Scilit:
- Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c‐kitBritish Journal of Haematology, 1992
- Myelodysplastic syndromes: A study of surface markers and in vitro growth patternsAmerican Journal of Hematology, 1990
- Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromesBritish Journal of Haematology, 1990
- Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid.Journal of Clinical Pathology, 1987
- Detection of cells of megakaryocyte lineage in haematological malignancies by immuno‐alkaline phosphatase labelling cell smears with a panel of monoclonal antibodiesBritish Journal of Haematology, 1987
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Expression of MY7 antigen on myeloid precursor cellsStem Cells, 1983
- A NEW MARKER FOR HUMAN CANCER CELLS. 3. IMMUNOCYTOCHEMICAL DETECTION OF MALIGNANT CELLS IN SEROUS FLUIDS WITH THE Cal ANTIBODYThe Lancet, 1982
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976